drugset / Trial / NCT00445250

The Role of Calcipotriol as Radioprotector of Skin

NCT00445250

Phase 2 Unknown 50 enrolled Rabin Medical Center
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Examining the hypothesis that protecting keratinocytes by calcipotriol can prevent in-vivo cutaneous side effect in patients receiving radiotherapy to the breast. To check the connection between the skin effect of radiotherapy and different parameters including diseases such as diabetes and lupus, use of medications, allergies, weight, habits, size of the irradiated breast, previous chemotherapy treatment and exposure to sunlight.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule Topical

Indications